343 related articles for article (PubMed ID: 19132123)
1. Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation.
Walker PA; Shah SK; Harting MT; Cox CS
Dis Model Mech; 2009; 2(1-2):23-38. PubMed ID: 19132123
[TBL] [Abstract][Full Text] [Related]
2. Treating childhood traumatic brain injury with autologous stem cell therapy.
Dewan S; Schimmel S; Borlongan CV
Expert Opin Biol Ther; 2018 May; 18(5):515-524. PubMed ID: 29421958
[TBL] [Abstract][Full Text] [Related]
3. G-CSF as an adjunctive therapy with umbilical cord blood cell transplantation for traumatic brain injury.
De La Peña I; Sanberg PR; Acosta S; Lin SZ; Borlongan CV
Cell Transplant; 2015; 24(3):447-57. PubMed ID: 25646620
[TBL] [Abstract][Full Text] [Related]
4. Advances in progenitor cell therapy using scaffolding constructs for central nervous system injury.
Walker PA; Aroom KR; Jimenez F; Shah SK; Harting MT; Gill BS; Cox CS
Stem Cell Rev Rep; 2009 Sep; 5(3):283-300. PubMed ID: 19644777
[TBL] [Abstract][Full Text] [Related]
5. Umbilical cord blood-derived stem cells and brain repair.
Sanberg PR; Willing AE; Garbuzova-Davis S; Saporta S; Liu G; Sanberg CD; Bickford PC; Klasko SK; El-Badri NS
Ann N Y Acad Sci; 2005 May; 1049():67-83. PubMed ID: 15965108
[TBL] [Abstract][Full Text] [Related]
6. Concise Review: Mesenchymal Stem Cells: From Roots to Boost.
Andrzejewska A; Lukomska B; Janowski M
Stem Cells; 2019 Jul; 37(7):855-864. PubMed ID: 30977255
[TBL] [Abstract][Full Text] [Related]
7. Clinical translation of stem cell therapy in traumatic brain injury: the potential of encapsulated mesenchymal cell biodelivery of glucagon-like peptide-1.
Heile A; Brinker T
Dialogues Clin Neurosci; 2011; 13(3):279-86. PubMed ID: 22034462
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of human oligodendrocyte progenitor cells in an animal model of diffuse traumatic axonal injury: survival and differentiation.
Xu L; Ryu J; Hiel H; Menon A; Aggarwal A; Rha E; Mahairaki V; Cummings BJ; Koliatsos VE
Stem Cell Res Ther; 2015 May; 6(1):93. PubMed ID: 25971252
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary delivery of bone-marrow-derived stem cells.
Bui QT; Gertz ZM; Wilensky RL
Stem Cell Res Ther; 2010 Sep; 1(4):29. PubMed ID: 20863415
[TBL] [Abstract][Full Text] [Related]
10. A review and rationale for the use of cellular transplantation as a therapeutic strategy for traumatic brain injury.
Schouten JW; Fulp CT; Royo NC; Saatman KE; Watson DJ; Snyder EY; Trojanowski JQ; Prockop DJ; Maas AI; McIntosh TK
J Neurotrauma; 2004 Nov; 21(11):1501-38. PubMed ID: 15684646
[TBL] [Abstract][Full Text] [Related]
11. Cell therapies for traumatic brain injury.
Harting MT; Baumgartner JE; Worth LL; Ewing-Cobbs L; Gee AP; Day MC; Cox CS
Neurosurg Focus; 2008; 24(3-4):E18. PubMed ID: 18341394
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury.
Acosta SA; Tajiri N; Shinozuka K; Ishikawa H; Sanberg PR; Sanchez-Ramos J; Song S; Kaneko Y; Borlongan CV
PLoS One; 2014; 9(3):e90953. PubMed ID: 24621603
[TBL] [Abstract][Full Text] [Related]
13. Stem Cell Sources and Their Potential for the Treatment of Retinal Degenerations.
Canto-Soler V; Flores-Bellver M; Vergara MN
Invest Ophthalmol Vis Sci; 2016 Apr; 57(5):ORSFd1-9. PubMed ID: 27116661
[TBL] [Abstract][Full Text] [Related]
14. Growth kinetics of human mesenchymal stem cells from bone marrow and umbilical cord blood.
Kang TJ; Yeom JE; Lee HJ; Rho SH; Han H; Chae GT
Acta Haematol; 2004; 112(4):230-3. PubMed ID: 15564740
[No Abstract] [Full Text] [Related]
15. Umbilical cord blood stem cell therapy in premature brain injury: Opportunities and challenges.
Peng X; Song J; Li B; Zhu C; Wang X
J Neurosci Res; 2020 May; 98(5):815-825. PubMed ID: 31797400
[TBL] [Abstract][Full Text] [Related]
16. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
17. Cell-based therapy for traumatic brain injury.
Gennai S; Monsel A; Hao Q; Liu J; Gudapati V; Barbier EL; Lee JW
Br J Anaesth; 2015 Aug; 115(2):203-12. PubMed ID: 26170348
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of mesenchymal and neural stem and progenitor cells on sensorimotor recovery after brain injury.
Poltavtseva RA; Silachev DN; Pavlovich SV; Kesova MI; Yarygin KN; Lupatov AY; Van'ko LV; Shuvalova MP; Sukhikh GT
Bull Exp Biol Med; 2012 Aug; 153(4):586-90. PubMed ID: 22977876
[TBL] [Abstract][Full Text] [Related]
19. Adipose tissue and stem/progenitor cells: discovery and development.
Kapur SK; Dos-Anjos Vilaboa S; Llull R; Katz AJ
Clin Plast Surg; 2015 Apr; 42(2):155-67. PubMed ID: 25827560
[TBL] [Abstract][Full Text] [Related]
20. Adult stem cells in bone and cartilage tissue engineering.
Salgado AJ; Oliveira JT; Pedro AJ; Reis RL
Curr Stem Cell Res Ther; 2006 Sep; 1(3):345-64. PubMed ID: 18220879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
